A biography of the vampire squid

Cover of 'What Happened to Goldman Sachs'
What Happened to Goldman Sachs

By Steven Mandis
Harvard Business Press Books (£18.99)
(Buy at Amazon)

There is no bank more notorious than Goldman Sachs. For many, it is the prime example of a greedy, self-obsessed institution that will stop at nothing to make money. So there is a large public appetite for books on the controversial firm. However, last year’s memoir by ex-trader Greg Smith was universally panned for focusing on personal anecdotes and lacking substance. What Happened to Goldman Sachs: An Insider’s Story of Organizational Drift and its Unintended Consequences, by former partner Steve Mandis, attempts to provide a more sober analysis.

Based on his PhD thesis for Columbia University, notes the FT’s Tom Braithwaite, it looks at Goldman’s transition “from partnership to public company and always-trusted adviser to often amoral traders”. It uses interviews with “over 50” people, including “partners, clients, competitors, equity research analysts, investors, regulators and legal experts”. However, the author “includes little of his own time at Goldman” from 1992 to 2004.

Mandis argues that, as a partnership, “Goldman de-emphasised the profit motive to give its employees a sense of higher purpose and to burnish that brand”, says Mary Kissel in The Wall Street Journal. However, in 1999 the end of the separation between investment and commercial banking led to “consolidation that gave other Wall Street firms bigger balance sheets to compete for Goldman’s clients” and best employees. It had to go public, forcing it to “balance the interests of investors and shareholders with those of its clients”. Stricter regulation also pushed Goldman “away from its business principles and toward the management of legal liability”.

But the book’s conclusion about the superiority of partnerships over listed firms is “the same as all the rest”, making it “wholly inadequate”, says David Bahnsen of blog The Bahnsen Viewpoint. Mandis doesn’t give enough detail about Goldman’s misdeeds, merely presupposing “some bad did take place”. We’re left waiting for a book that asks whether “anything has gone wrong at Goldman” and if the media and regulators’ response was “proportionate”.

Actually, this is an “accessible” book that includes a timeline and biographies of its leaders, says Peter Lattman of The New York Times Dealbreaker blog. Anyone who thinks the bank unfairly criticised should look at the book’s “list of Goldman partners at the time of its initial public offering and the value of their stock holdings after the first day of trading”.

• What Happened to Goldman Sachs: An Insider’s Story of Organizational Drift and its Unintended Consequences, by Steven Mandis, is published by Harvard Business Press Books (£18.99).(Buy from Amazon.co.uk)

• Stay up to date with MoneyWeek: Follow us on TwitterFacebook and Google+


 

MoneyWeek magazine

Latest issue:

Magazine cover
China's cash problem

How to profit from it

The UK's best-selling financial magazine. Take a FREE trial today.
Claim 4 FREE Issues

Bill Bonner: hold on to your cash, the real financial crisis is yet to come

Merryn Somerset Webb talks to Bill Bonner about economic cycles, and the 'catastrophic credit crisis' that will make 2008 look like a picnic.


Which investment platform?

When it comes to buying shares and funds, there are several investment platforms and brokers to choose from. They all offer various fee structures to suit individual investing habits.
Find out which one is best for you.


6 March 1899: Bayer trademarks Aspirin

Chemical company Bayer was awarded a patent for its pain-relieving acetylsalicylic acid powder, or 'Aspirin', on this day in 1899. It would soon be released in tablet form.